Fed. Circ. Affirms Merck Win In Vytorin, Zetia Patent Case
The Federal Circuit ruled Thursday that a Merck & Co. Inc. unit can enforce a patent for an active ingredient in the cholesterol drugs Vytorin and Zetia, snuffing out generic-drug maker...To view the full article, register now.
Already a subscriber? Click here to view full article